Mutations in BRCA2 confer a higher risk for developing cancers of the pancreas and male breast, and BRCA1 mutations seem to be predominantly associated with a higher risk for developing peritoneal and fallopian tube cancer. The gene discussed is BRCA2; the disease is fallopian tube cancer.